International Conference on
Central Nervous System - Drug Effects & Novel Drug Development
September 5-7, 2012 DoubleTree by Hilton Philadelphia, USA
Central Nervous System-2012
Participants List in Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
University Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
University de Sao Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List From Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Womens Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddys labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
International Conference on Central Nervous System-Drug Effects & Novel Drug Development , will be organized around the theme "Novel Therapeutic Approaches in Control of CNS Disorders."
Central Nervous System-2012 is comprised of 13 tracks and 68 sessions designed to offer
comprehensive sessions that address current issues in Central Nervous System.
Submit your abstract to any of the following tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Track 1: Drug Discovery and Development in Neurosciences
Track 1-1
Neuropharmacology, ADME/T in drug discovery
Track 1-2
Anti-neurodegenerative drug discovery
Track 1-3
Ion channels, transporters and neurotransmitter receptors
Track 1-4
Neural stem cells and gene or cell therapy
Track 1-5
Neurotransmitters, neuromodulators, and neuroreceptors
Track 1-6
Centrally acting analgesics
Track 2: Drug Metabolism in Drug Design
Track 2-1
Blood brain barrier (BBB)
Track 2-2
Metabolism mediated drug-drug interactions
Track 2-3
Enzyme kinetics
Track 2-4
Role of drug metabolism in drug development
Track 2-5
Nanoparticles as drug carriers
Track 3: Clinical Trials on CNS
Track 3-1
Clinical development in MS, PD and AD
Track 3-2
Biomarkers implication in clinical trials
Track 3-3
Schizophrenia and depression
Track 3-4
Current challenges in translational CNS research
Track 3-5
Facilitating and establishing industry and academic partnering
Track 4: Neurological Drug Targets
Track 4-1
Properties of drug molecules
Track 4-2
Therapeutic target discovery
Track 4-3
Target validation
Track 4-4
Lead optimization
Track 4-5
Drug delivery systems
Track 5: Disorders Related to CNS
Track 5-1
Acoustic neuroma
Track 5-2
Encephalitis
Track 5-3
Juvenile huntington disease
Track 5-4
Spinal meningitis
Track 5-5
Motor neuron disease
Track 5-6
Hydrocephalus
Track 5-7
Therapeutics of sleep disorders
Track 6: Neurodegenerative Diseases and Neurorehabilitation
Track 6-1
Alzheimer's disease
Track 6-2
Parkinsonism
Track 6-3
Down's syndrome
Track 6-4
Schizophrenia
Track 6-5
Autism
Track 6-6
Migraine and headaches
Track 6-7
Huntington disease
Track 6-8
Movement disorders, neuromyopathy, and peripheral nerve disorder
Track 7: Diagnostics in CNS disorders
Track 7-1
Neuro imaging techniques
Track 7-2
Diagnosis for cerebral infections
Track 7-3
Genetic testing for neurological disorders
Track 8: Therapeutics in Behavioral Neurology
Track 8-1
Agnosias, aphasias and anosognosia
Track 8-2
Amnesias and dementias
Track 8-3
Traumatic brain injury and brain death
Track 8-4
Attention deficit hyperactivity disorder (ADHD)
Track 9: Neuroimmunology
Track 9-1
Neural stem cells and neurosurgery
Track 9-2
Neurodevelopmental diseases and thermogenesis
Track 9-3
Neuroimmunological disorders
Track 9-4
Neuro epidemiology
Track 9-5
Neuromics, neuroproteomics, neurogenomics and human brain proteome
Track 10: Pediatric neurology
Track 10-1
Epilepsy in children, epilepsy prevention and management
Track 10-2
Neurosurgery in epilepsy
Track 10-3
Autistic children
Track 10-4
Hydrocephalus in children
Track 10-5
Krabbe disease
Track 11: Current trends in Neurophysiology
Track 11-1
Clinical neurophysiology and electrophysiology
Track 11-2
Cerebral CSF flow studies
Track 11-3
Electromyography, electroencephalography (EEG)
Track 11-4
Evoked potentials
Track 11-5
Polysomnography
Track 12: Oncology of Central Nervous System
Track 12-1
Innovative therapies for brain cancers
Track 12-2
Chemotherapy for brain tumors
Track 12-3
Radiation therapy for brain tumors
Track 12-4
Pediatric neuro cancers
Track 13: CNS Biomarkers
Track 13-1
Supporting CNS drug development using biomarkers
Track 13-2
Cerebral CSF flow studies
Track 13-3
Cerebrospinal fluid biomarkers
Track 13-4
Anti-amyloid therapies for Alzheimer's disease
Track 13-5
Technology case studies for CNS